Cargando…

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease

Interstitial lung disease (ILD) represents a severe pulmonary complication of connective tissue diseases, rheumatoid arthritis (RA), and antineutrophil cytoplasmic antibody-associated vasculitis. Treatment of ILD, mainly based on immunosuppression, remains challenging. Rituximab (RTX), a monoclonal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vacchi, Caterina, Manfredi, Andreina, Cassone, Giulia, Erre, Gian Luca, Salvarani, Carlo, Sebastiani, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813433/ https://www.ncbi.nlm.nih.gov/pubmed/33505478 http://dx.doi.org/10.7573/dic.2020-8-7

Ejemplares similares

Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review
por: Cassone, Giulia, et al.
Publicado: (2021)

Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
por: Vacchi, Caterina, et al.
Publicado: (2020)

Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease
por: Vacchi, Caterina, et al.
Publicado: (2020)

Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?
por: Cassone, Giulia, et al.
Publicado: (2020)

Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases
por: MANFREDI, Andreina, et al.
Publicado: (2020)

Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows
por: Cassone, Giulia, et al.
Publicado: (2020)

Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study
por: Cassone, Giulia, et al.
Publicado: (2020)

Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis
por: Vacchi, Caterina, et al.
Publicado: (2021)

Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey
por: Sebastiani, Marco, et al.
Publicado: (2022)

Erratum to acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature
por: Manfredi, Andreina, et al.
Publicado: (2020)

Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
por: Erre, Gian Luca, et al.
Publicado: (2021)

Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential
por: Sebastiani, Marco, et al.
Publicado: (2020)

Personalized Medicine and Machine Learning: A Roadmap for the Future
por: Sebastiani, Marco, et al.
Publicado: (2022)

Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study
por: Sebastiani, Marco, et al.
Publicado: (2023)

Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
por: Scirocco, Chiara, et al.
Publicado: (2020)

Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
por: Erre, Gian Luca, et al.
Publicado: (2021)

Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
por: Erre, Gian Luca, et al.
Publicado: (2020)

Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study
por: Venerito, Vincenzo, et al.
Publicado: (2023)

Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association
por: Sebastiani, Marco, et al.
Publicado: (2021)

VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds
por: Pancaldi, Fabrizio, et al.
Publicado: (2022)

Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease
por: León Román, Francisco, et al.
Publicado: (2023)

Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma
por: Colaci, Michele, et al.
Publicado: (2014)

Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease–Associated Interstitial Lung Disease
por: Zhu, Lisa, et al.
Publicado: (2020)

Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study
por: Venerito, Vincenzo, et al.
Publicado: (2023)

Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis
por: Dei, Giulia, et al.
Publicado: (2020)

Rituximab for the treatment of connective tissue disease–associated interstitial lung disease: A systematic review and meta-analysis
por: Xu, Linrui, et al.
Publicado: (2022)

Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
por: Al Tabaa, Omar, et al.
Publicado: (2023)

Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection
por: Cassone, Giulia, et al.
Publicado: (2013)

Lung complications of Sjogren syndrome
por: Luppi, Fabrizio, et al.
Publicado: (2020)

Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study
por: Mena-Vázquez, Natalia, et al.
Publicado: (2022)

Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial
por: Saunders, Peter, et al.
Publicado: (2017)

Effect size of rituximab on pulmonary function in the treatment of connective-tissue disease-related interstitial lung disease: a systematic review and meta-analysis
por: Zhao, Yuanchen, et al.
Publicado: (2022)

A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment
por: Calderazzo, Massimo, et al.
Publicado: (2015)

The Efficacy and Safety of Rituximab in Patients with Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease: Case Series
por: Jang, Youngeun, et al.
Publicado: (2023)

Interstitial lung disease in suggestive forms of connective tissue disease
por: Fischer, Aryeh
Publicado: (2013)

Pneumothorax in connective tissue disease-associated interstitial lung disease
por: Nishimoto, Koji, et al.
Publicado: (2020)

Management of Connective Tissue Disease–related Interstitial Lung Disease
por: Ahmed, Sakir, et al.
Publicado: (2022)

Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)

Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis
por: Sainz-Prestel, Valeria, et al.
Publicado: (2013)

Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases
por: Nucera, Valeria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j2f3giq9fa18mg0q2oiknti95n